Immune Health Supplement Market to Surpass US$ 24,951.0 Million by 2027 - Coherent Market Insights

Global Immune Health Supplement Market, By Ingredients (Vitamins, Omega-3 Fatty Acids, Probiotics, Minerals, and Others), By Source (Plant-based, and Animal-based), By Form (Tablets, Capsules, Powder, and Liquid), By Distribution Channel (Hypermarkets/Supermarkets, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - is estimated to be valued at US$ 15,441.9 Mn in 2020 and is expected to exhibit a CAGR of 7.1% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.

The product launches and approvals are expected to propel growth of the global immune health supplement market over the forecast period. For instance, in June 2020, Otsuka Pharmaceutical Factory Inc. launched its new ENORAS Liquid for enteral use, in coffee and strawberry flavors. It is indicated to be used as a nutritional support for postoperative patients.

Furthermore, in April 2020, Gerber, a company that specializes in early-childhood nutrition, launched two A2 milk innovations including Gerber Good Start A2 Infant Formula and Good Start A2 Toddler Drink. Both products contain a combination of easy-to-digest A2 β-casein protein and probiotics & prebiotic HMO (Human Milk Oligosaccharide) to support digestive health of the baby.

Global Immune Health Supplement Market– Impact of Coronavirus (COVID-19) Pandemic

The coronavirus pandemic has negatively impacted the development, production, and supply of immune health supplement market worldwide. Many production, manufacturing facilities, and transport departments have suspended activities in their immune health supplement factories to stop the spread of coronavirus. Thus, this pandemic has affected both demand and supply of immune health supplement market. Since December 2019, a novel coronavirus spread throughout China and across the world, causing a continuous increase in confirmed cases within a short period of time. The disease has spread to more than 100 countries across the globe with the World Health Organization declaring it a public health emergency in March 2020. For instance, according to the World Health Organization Coronavirus Disease (COVID-19) report, the manifestation of the coronavirus disease has resulted in more than 166 million infected individuals worldwide as of 23^rd May 2021. Following the spread of the coronavirus, several companies operating in the immune health supplement market are investing in the development of new immune health supplement products to boost immunity in the body. For instance, Danone’s nutrition health department, Nutricia, is supporting research from independent medical professionals to define guidelines for nutritional care for COVID-19 patients recovering after intensive care unit (ICU) discharge. In May 2020, Danone’s nutrition health department, Nutricia, announced that clinician-initiated research projects in 16 countries across the world will be supported by Nutricia with grants totaling to around US$ 1.1 million.

Browse 43 Market Data Tables and 38 Figures spread through 216 Pages and in-depth TOC on “Global Immune Health Supplement Market”- Forecast to 2027, Global Immune Health Supplement Market , By Ingredients (Vitamins, Omega-3 Fatty Acids, Probiotics, Minerals, and Others), By Source (Plant-based and Animal-based), By Form (Tablets, Capsules, Powder, and Liquid), By Distribution Channel (Hypermarkets/Supermarkets, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

https://www.coherentmarketinsights.com/market-insight/immune-health-supplements-market-4065

Moreover, increasing prevalence of chronic diseases and other disorders in geriatric patients is also expected to aid in growth of the global immune health supplement market over the forecast period. For instance, according to World Population Prospects, in 2017, the global geriatric population was around 962 million, which is expected to reach around 2.1 billion by the year 2050.

Key Takeaways of the Global Immune Health Supplement Market:

• The global immune health supplement market is expected to exhibit a CAGR of 7.1% during the forecast period due to launch of immune health supplement products, this is expected to boost growth of the market. For instance, in April 2017, Cambrooke Therapeutics Inc. launched Tylacti COMPLETE Bars, a nutritionally complete medical food available for dietary management of Tyrosinemia (TYR). Furthermore, in September 2016, Cambrooke Therapeutics Inc. launched a new and improved Glytactin Complete Bar, a medical food for the dietary management of Phenylketonuria (PKU).
• Among Sources, Plant-based segment is estimated to hold largest market share in the global immune health supplement market over the forecast period. The increasing development and launch of plant-based immune health supplements is expected to drive the segment growth over the forecast period. For instance, in March 2020, a New Zealand-based dietary supplement firm, Vitality Wellness, launched an immune health supplement that is made from blackcurrants along with additional nutrients such as vitamin C, vitamin D, zinc etc.
• On the basis of form, Capsules segment is accounted for the largest market share in global immune health supplement market over the forecast period. The capsule form of supplements have certain advantages over the tablet form, such as, easy digestibility, no unpleasant taste or odor, higher bioavailability etc. Thus, such advantages offered by capsules are expected to drive the segment growth over the forecast period.
• Major players operating in the global immune health supplement market are Abbott Nutrition, Bayer AG, Glanbia, Plc., EuroPharma, Inc., Bio Tech Pharmacal, Vital Nutrients, Herbalife Nutrition Ltd, Vitabiotics Ltd., NutriGold Inc., BioGaia, Natural Immunogenics, and Nutramax Laboratories